iiinova — where your digital self keeps evolving

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 24/09/2026

🧵(1/3) NSW respiratory surveillance reports: 24 September 2026 Week ending 19 September 2026 🔸COVID positivity rate: 2.2% (-0.5%) 🔸Number of laboratories reporting COVID: 3 out of 4 🔹COVID: 596 (-15.2%) 🔹Influenza: 5,425 (-6.9%) 🔹RSV: 848 (-12.9%) Source: health.nsw.gov.au/Infectious/c...

The image shows a NSW Respiratory Surveillance Report from the NSW Government, for the week ending 19 September 2026.
A prominent bold headline states: "Influenza is at a high level of activity. COVID-19 is at a low level of activity. RSV is at a low level of activity."
The "Summary" section notes that influenza activity decreased but remains high, COVID-19 remains low, and RSV activity decreased to a low level. It strongly recommends influenza vaccination.
The "Data sources and methods" section explains how NSW Health monitors respiratory viruses. It notes that public registration of positive COVID-19 rapid antigen tests (RAT) in NSW ceased on 30 September 2023. It states that wastewater surveillance, genomic sequencing, and sentinel laboratory networks are currently of most value for monitoring COVID-19. Finally, it mentions that data sources update as information becomes available, meaning the report cannot be directly compared to previous versions or reporting periods.

The image displays Table 1: Notifications of COVID-19, influenza and RSV, NSW, tested in the week ending 19 September 2026.
An introductory text interpretation states that in the past week, there was a decrease of 15.2% in COVID-19 notifications, a decrease of 6.9% in influenza notifications, and a decrease of 12.9% in RSV notifications.
The table breaks down positive cases by Gender, Age group, and Local Health District of residence across three main categories: COVID, Influenza, and RSV. Each virus shows metrics for both the single "Week ending 19 September 2026" and the "Year to Date".
Key total weekly counts listed at the bottom are:
• COVID: 596 weekly notifications (33,537 Year to Date)
• Influenza: 5,425 weekly notifications (76,593 Year to Date)
• RSV: 848 weekly notifications (54,914 Year to Date)

The image shows Figure 6: Weekly notifications of COVID-19, Influenza and RSV, by date of test and type of test performed, NSW, tracking data from 1 March 2025 to 19 September 2026.
It contains three separate bar charts vertically stacked:
• COVID-19: Shows a major peak of over 4,000 weekly notifications around June/July 2025, followed by a steady decline. Numbers remained lower through 2026, hovering around 1,000 weekly notifications before declining further by September 2026.
• Influenza: Shows a seasonal peak in July/August 2025 reaching over 8,000 weekly cases. The 2026 winter season peaked later and lower, around late August/September 2026, reaching nearly 8,000 cases. A legend breaks down influenza by type (Type A, Type B, Type A&B, untyped).
• RSV: Shows a 2025 peak around June/July at over 3,000 weekly cases. The 2026 season peaked similarly in June/July, reaching just under 3,000 notifications before dropping steadily through September 2026.

The image features data from NSW sentinel laboratories tracking COVID-19 test positivity from 1 March 2025 to 20 September 2026.
An introductory text interpretation states that in the last week, COVID-19 test positivity decreased to 2.2%, influenza decreased to 17.7%, and RSV decreased to 1.7%.
The image contains two main components:
• Figure 13: A line and bar graph showing the "Number and proportion of tests positive for COVID-19". The percentage line peaks at 7.3% in July 2025 and trends downward, showing minor fluctuations before hitting 2.2% in September 2026.
• Table 2: A data table breakdown for the four weeks ending 30 August to 20 September 2026. For the final week ending 20 September, it highlights 231 positive cases (2.2% positivity) out of 10,580 PCR tests conducted across 3 reporting laboratories. Both the 2.2% figure and the number 3 are circled in red.

24914

Reposted by Dr Satoshi Akima, FRACP

Nephrology Journal Club @nephjc.bsky.social · 02/09/2026

1/10 #NephJC #TenPostNephJC Validation of an AI model is difficult. 🤖 Enter the REFINe trial (Reasoning Enhancement With Feedback From a Generative AI in Nephrology), a RCT of large language model (LLM) -assisted diagnostic accuracy in nephrology. www.kireports.org/article/S246...

154

Reposted by Dr Satoshi Akima, FRACP

Dr David Joffe MB BS(Hons), PhD, FRACP @davidjoffe64.bsky.social · 30/08/2026

Now I know why everyone left Twitter... What an awful place to try and shared science and help people... @toshiakima.bsky.social you were right!

10655

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 22/08/2026

"Covid-19: 40% of affected healthcare workers had long covid, and a quarter still had symptoms after a year" Published: 20 August 2026 Source: www.bmj.com/content/394/...

An infographic features a stressed female healthcare worker in blue scrubs leaning against a hospital corridor wall with her hand to her forehead. On the left, large text overlays state: "40% of affected healthcare workers had long COVID" and "25% still had symptoms after a year."

114361

Reposted by Dr Satoshi Akima, FRACP

Robert Reich @rbreich.bsky.social · 21/08/2026

Food companies wanted deregulation. Now there are dozens of recalls across the country. Mining companies wanted deregulation. Now the black lung rate is at a 45-year high. Financial companies wanted deregulation. Now financial losses to fraud are the highest on record. Noticing a pattern?

795198377888

Reposted by Dr Satoshi Akima, FRACP

Prof Deborah Lupton, MPH PhD @dalupton.bsky.social · 21/08/2026

There’s a huge change coming to COVID vaccine access policy in Australia. From 1 October, many people will no longer be eligible for a free vaccine. Terrible policy 😡 www.health.gov.au/resources/pu...

health.gov.au

1913177

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 21/08/2026

AUSTRALIA Weekly COVID Update: 21 August 2026 🔹TAS: ⬆️ (+51.1%) 🔹SA: ⬆️ (+40.6%) 🔹QLD: ⬆️ (+14.2%) 25 in hospital 🔹NSW: ⬆️ (+4.6%) 🔹VIC: ⬆️ (+4.0%) 🔹WA: ⬆️ (+3.9%) 39/day in hospital 🔸ACT: ⬇️ (-3.0%) 🔹Aged Care: The government ended weekly reporting

An "AUSTRALIAN Weekly COVID Update — 21 August 2026" summary dashboard page listing states and territories, case trends, percentage changes, and reporting notes.
Six jurisdictions show an upward trend:
• TAS: UP, +51.1% change. Fortnightly update, positivity rate 5.1%.
• SA: UP, +40.6% change. Weekly update, 1 death reported.
• QLD: UP, +14.2% change. Weekly update, 25 in hospital.
• NSW: UP, +4.6% change. Weekly update, positivity rate 2.9%.
• VIC: UP, +4.0% change. Fortnightly update, positivity rate 2.8%.
• WA: UP, +3.9% change. Weekly update, average of 39 per day in hospital, positivity rate 3.9%.
One jurisdiction shows a downward trend:
• ACT: DOWN, -3.0% change. Weekly update.
Two sections list discontinued data:
• NT: COVID data is no longer published on the NT Health's website.
• Aged care: The Australian Government no longer publishes weekly COVID-19 case data for Australian residential aged care facilities.

25925

Reposted by Dr Satoshi Akima, FRACP

Ian Weissman, DO @drianweissman.bsky.social · 15/08/2026

"Long-term exposure to air pollution is associated with more advanced coronary atherosclerosis, including greater plaque burden and obstructive coronary artery disease." cardiovascularbusiness.com/topics/preve...

cardiovascularbusiness.com

Cardiac CT links air pollution to increased risk of coronary disease

Cardiac CT scans may give clinicians a way to visualize the effects of environmental exposure before cardiovascular events even occur.

14021

Reposted by Dr Satoshi Akima, FRACP

Ian Weissman, DO @drianweissman.bsky.social · 15/08/2026

"We're again in the midst of a growing summer surge of COVID here in the United States. Most of us hope that it had faded away, but nationally we're seeing it ticking up pretty much everywhere and people are still dying from it." www.npr.org/2026/08/14/n...

npr.org

Is there a summer COVID-19 surge this year? Yep, it's ramping up again

Just like all previous summers since the pandemic began, COVID-19 cases are ticking up again, even while other health threats make more headlines.

67954

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 13/08/2026

🧵(1/3) NSW respiratory surveillance reports: 13 August 2026 Week ending 8 August 2026: 🔸COVID positivity rate: 3.6% (+0.2%) 🔸Number of laboratories reporting COVID: 2 out of 4 🔹COVID: 926 (+6.1%) 🔹Influenza: 4,306 (+38.2%) 🔹RSV: 1,534 (-10.9%) Source: health.nsw.gov.au/Infectious/c...

The image presents a comprehensive data table from NSW Health tracking viral respiratory notifications in New South Wales for the week ending 8 August 2026.
At the top, an introductory interpretation statement notes a 6.1% weekly increase in COVID-19 notifications, a 38.2% spike in influenza cases, and a 10.9% drop in RSV.
The main matrix, "Table 1," is split into three core vertical columns: COVID, Influenza, and RSV. Each virus category contains two metrics: "Week ending 8 August 2026" and "Year to Date".
The horizontal rows segment these viral numbers across three specific demographics: Gender (Female and Male), Age Group (ranging from 0–4 up to 90+), and Local Health District of Residence (such as Central Coast, Northern Sydney, and Western Sydney). The bottom row displays the final totals for the week: 926 for COVID, 4,306 for Influenza, and 1,534 for RSV.

The image features "Figure 6," a stacked bar chart displaying weekly notifications for COVID-19, Influenza, and RSV in NSW from 1 February 2025 to 8 August 2026.
The data is separated into three distinct stacked vertical bar sub-graphs:
• COVID-19 (top): Shows a prominent mid-2025 peak reaching over 4,000 weekly notifications, followed by a lower, steady wave through mid-2026 hovering around 1,000 notifications.
• Influenza (middle): Features a color-coded legend detailing test types (Influenza - Type A, Type B, Type A&B, and untyped). It exhibits a strong winter 2025 peak near 8,000 cases and a sharp, recent upward spike in July–August 2026 approaching 4,500 cases.
• RSV (bottom): Shows distinct cyclical winter peaks, climbing to over 3,000 notifications in June 2025 and rising to nearly 3,000 weekly notifications around June–July 2026 before trailing downward.
Each sub-graph tracks "Weekly notifications" on its y-axis against "Test date" month intervals on its x-axis.

The image presents viral testing metrics from NSW sentinel laboratories, tracking data from 1 February 2025 to 9 August 2026.
At the top, an interpretation states COVID-19 test positivity increased to 3.6%, Influenza rose to 13.4%, and RSV decreased to 3.5%.
Below this is "Figure 13," a dual-axis chart showing "Number of positive tests" as light blue bars against a dark grey line representing "Percent positive (%)". The line shows a peak of 7.3% in July 2025, a low baseline through early 2026, and a gradual recent rise to 3.6% by August 2026.
The bottom section features "Table 2," broken down by week ending dates: 19 July, 26 July, 02 August, and 09 August. For the week ending 09 August, a red circle highlights a 3.6% positivity rate for SARS-CoV-2 (from 362 positive cases out of 10,181 PCR tests conducted). Another red circle in the final row highlights that only 2 laboratories reported data that week.

36122

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 14/08/2026

AUSTRALIA Weekly COVID Update: 14 August 2026 🔹ACT: ⬆️(+44.4%) 🔹QLD: ⬆️(+8.8%) 21 in hospital 🔹NSW: ⬆️(+6.1%) 🔸SA: ⬇️(-26.4%) 🔸WA: ⬇️(-8.2%) 45/day in hospital 🔹TAS: Next update: 21 August 🔹VIC: Next update: 21 August 🔹Aged Care: The government ended weekly reporting

A data table titled "AUSTRALIAN Weekly COVID Update — 14 August 2026" tracking regional trends across Australian states and territories.
The table features four columns: "States & Territories," "Trend," "% Change," and "Reporting Notes."
Key metrics for active regions include:
• ACT: Trend is UP, +44.4% change, noted as a weekly update.
• QLD: Trend is UP, +8.8% change, noted with 21 in hospital.
• NSW: Trend is UP, +6.1% change, noted with a positivity rate of 3.6%.
• SA: Trend is DOWN, -26.4% change, noted as a weekly update.
• WA: Trend is DOWN, -8.2% change, noted with an average of 45 per day in hospital and a 3.8% positivity rate.
The remaining rows (VIC, TAS, NT, Aged care) feature dashes under trend and percentage columns. Notes indicate VIC and TAS expect updates on 21 August, while NT and Aged care data are no longer published weekly.

16515

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 14/08/2026

Australian Respiratory Surveillance Report – 14 August 2026 Reported cases in the last fortnight (27 July to 9 August 2026) 🔸COVID: 4,148 (+15.9%) 🔸Influenza: 13,685 (+58.4%) 🔸RSV: 10,100 (-15.3%) Source: www.cdc.gov.au/resources/pu...

05224

Reposted by Dr Satoshi Akima, FRACP

PolyBio Research Foundation @polybiorf.bsky.social · 10/08/2026

PolyBio is supporting research that investigates the bone marrow as a potential long-term SARS-CoV-2 reservoir site. Bone marrow-derived cells, including megakaryocytes and the platelets they produce, have previously been shown to contain SCV2 double-stranded RNA in Long COVID patients’ samples— 1/

1179

Reposted by Dr Satoshi Akima, FRACP

AusPoast @daryltractor.bsky.social · 10/08/2026

Really makes you think

Got the COVID vax and 5 years later… BOOM.
Jury duty.
dr_asherwilliams_

Starting to connect the dots..what side effects are the rest of you having?

jaime_oliveoil 1d
You're on to something... I got the covid Vax and now I have a bob. Something aint right here

themarissamay_ 1d
I got the vax and now I'm five years older. WAKE UP PEOPLE

mar_it_zaa 20h
Got the jab THREE times and now my fridge won't make ice. Make it make sense!

qui3tstorm_v 1d
My rent went up!! Should've never gotten the jab

saffrodon 21h
they are putting something in the water that makes you PISS

1496

Reposted by Dr Satoshi Akima, FRACP

Taylor Lorenz @taylorlorenz.bsky.social · 03/03/2026

1908: the Lancet, one of the most respected scientific journals, calls for 18 age limit on reading in bed amidst a moral panic surrounding children becoming "addicted" to novels, which were "designed to keep kids hooked" and destroy their attention/mental health

32649914

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 08/08/2026

World Health Organization Surveillance Dashboard Reporting Period: 27 July 2026 – 2 August 2026 Latest SARS-CoV-2 Test Positivity Rates (Week 31) 1. Netherlands: 71.4% 2. Venezuela: 40.0% 3. El Salvador: 33.3% 4. Guatemala: 14.2% 5. Cayman Islands: 13.6% Source: app.powerbi.com/view?r=eyJrI...

65631

Reposted by Dr Satoshi Akima, FRACP

Denis - The COVID Info Guy @thecovidinfoguy.bsky.social · 06/08/2026

🧵(1/3) NSW respiratory surveillance reports: 6 August 2026 Week ending 1 August 2026: 🔸COVID positivity rate: 3.5% (+0.5%) 🔸Number of laboratories reporting COVID: 2 out of 4 🔹COVID: 873 (+13.4%) 🔹Influenza: 3,116 (+24.2%) 🔹RSV: 1,722 (-6.8%) Source: health.nsw.gov.au/Infectious/c...

A screenshot of the NSW Respiratory Surveillance Report for the week ending 1 August 2026 from the NSW Government health website. A prominent bold callout box at the top states: "Influenza is at a moderate level of activity. COVID-19 is at a low level of activity. RSV is at a moderate level of activity." Under the Summary section, the text reiterates these activity levels and adds that influenza vaccination is recommended now, and RSV vaccines for older adults are now available. The lower half of the document contains a "Data sources and methods" section explaining how NSW Health monitors community transmission through emergency data, wastewater surveillance, and genomic sequencing, noting that public registration of positive COVID-19 rapid antigen tests ceased on 30 September 2023.

An image displaying a data table from the NSW Respiratory Surveillance Report for the week ending 1 August 2026. The text interpretation at the top notes a weekly increase of 13.4% in COVID-19 notifications and 24.2% in influenza notifications, alongside a 6.8% decrease in RSV notifications.
The main table breaks down notifications for COVID-19, Influenza, and RSV by the specific week versus Year to Date, categorized by demographic groups:
• Gender: Shows counts and percentages for Female and Male patients across all three viruses.
• Age group (years): Spans from 0-4 up to 90+. Notably, the 0-4 age group accounts for 46% (21,417 cases) of Year to Date RSV notifications.
• Local Health District of residence: Lists case numbers across regions like Northern Sydney, South Western Sydney, and Western Western Sydney. Western Sydney shows the highest Year to Date numbers, including 8,284 Influenza cases (25%).
The table totals at the bottom list 873 weekly COVID cases, 3,116 Influenza cases, and 1,722 RSV cases.

An image titled "Figure 6. Weekly notifications of COVID-19, Influenza and RSV, by date of test and type of test performed, NSW, 1 February 2025 to 1 August 2026." It contains three stacked bar charts tracking weekly respiratory virus notifications.
• COVID-19 (Top): Dark blue bars show a massive peak in July 2025 near 4,000 weekly cases. In 2026, cases remain steady and low, hovering around 1,000 cases through winter.
• Influenza (Middle): Features multi-shaded blue bars tracking virus strains. A massive peak occurred in July–August 2025, topping 8,000 weekly cases. The 2026 winter wave shows a smaller, steady climb to roughly 3,000 cases by August.
• RSV (Bottom): Dark blue bars illustrate a peak in June 2025 at over 3,000 weekly cases. Unlike the other two viruses, the 2026 winter wave is tracking higher than the previous year, peaking in June–July 2026 near 3,000 weekly cases.
All three charts drop off abruptly at the far right for August 2026.

An image titled "Figure 13. Number and proportion of tests positive for COVID-19 at NSW sentinel laboratories by week, 1 February 2025 to 2 August 2026." Text at the top notes COVID-19 positivity rose to 3.5%, influenza to 10.2%, and RSV dropped to 4.1%.
• Line and Bar Graph: Tracks test counts (light blue bars) and percent positive (dark grey line). The positivity rate peaked at 7.3% in July 2025, bottomed out at 2.4% in December 2025, and climbed to 3.5% by August 2026.
• Table 2: Details COVID-19 notifications across four weeks ending August 2, 2026. For the week ending August 2, total SARS-CoV-2 cases reached 376 out of 10,722 PCR tests conducted.
Two red circles highlight key data points for the week ending August 2: a 3.5% positivity rate on the far right, and the number "2" indicating only two laboratories reported COVID data that week, down from three in previous weeks.

14312

Reposted by Dr Satoshi Akima, FRACP

International Society on Thrombosis and Haemostasis @isth.org · 06/08/2026

🚨Can we use standard D‑dimer thresholds in postpartum patients? How should we manage suspected PE during the postpartum period? Our JTH Research Recap dives into this topic! 📰Read the paper: www.jthjournal.org/article/S1538-7836(26)00333-8/fulltext 📽️Watch the recap: www.youtube.com/watch?v=w6-p...

031

Dr Satoshi Akima, FRACP @toshiakima.bsky.social · 06/08/2026

This looks interesting. COVID has revolutionised our appreciation of viruses as molecular effectors of disease, and we will never look at cardiovascular inflammation in the same light again. na.eventscloud.com/website/97098/

na.eventscloud.com

Unmasking Viral Triggers: Adult Immunization and the Mechanisms of Cardiovascular Risk ̶ A Case-Based ExplorationHome

Activity Overview

14913

Reposted by Dr Satoshi Akima, FRACP

NEJM.org @nejm.org · 05/08/2026

Platelet-activating antibodies against platelet factor 4 cause highly prothrombotic disorders with reduced platelet counts, including heparin-induced thrombocytopenia and vaccine-induced immune thrombocytopenia and thrombosis. Learn more: nej.md/4fskK0r

A bullet list of key points from the Review Article "Platelet-Activating Anti–Platelet Factor 4 Disorders" on a yellow background. The New England Journal of Medicine identity sits at the bottom.

083

Reposted by Dr Satoshi Akima, FRACP

🦋Dr. Natalia🕊🌻🪬 @solnatamd.medsky.social · 04/08/2026

Politicians are back to building political strategy on COVID. Here we go again — 2020. And it's triggering frontline healthcare workers to post photos of themselves from back then — in masks, in plastic gowns, in trash bags.

14016

Reposted by Dr Satoshi Akima, FRACP

Eric Topol @erictopol.bsky.social · 31/07/2026

Less protein, more lifespan! A comprehensive review of the merits of protein restriction for healthy aging A flip from the proteinmaxxing craze cell.com/cell-press-b...

1618960

Reposted by Dr Satoshi Akima, FRACP

Hilda Bastian @hildabast.bsky.social · 04/08/2026

Introducing the NextGen Covid Vax Tracker! vaxtracker.wordpress.com/2026/07/29/i... A monthly update on vaccine progress, featured vaccines, analyses, plus lots of background info. #Vaccines #Covid #Covid19

A happy vaccine (Cartoon by Hilda Bastian)

34615

Reposted by Dr Satoshi Akima, FRACP

Dr. Lucky Tran @luckytran.com · 02/08/2026

I worked for New York’s largest medical center at the start of the pandemic. There were morgue trucks on the streets. They set up emergency medical tents in Central Park. Healthcare worker colleagues died. It is horrific that RFK Jr is on national TV lying that ICUs were empty.

22672984310342

Reposted by Dr Satoshi Akima, FRACP

JAMA @jama.com · 03/08/2026

Among patients undergoing elective cardiac surgery, perioperative #dapagliflozin reduced postoperative #AcuteKidneyInjury compared with placebo over 7 days. ja.ma/4w8UXPZ

JAMA study on dapagliflozin for acute kidney injury (AKI) after elective cardiac surgery. 784 patients randomized. Dapagliflozin (28% AKI) vs. Placebo (52% AKI). Dapagliflozin significantly reduced postoperative AKI incidence by 23.98%.

072

Reposted by Dr Satoshi Akima, FRACP

Nikkei Asia (Official) @asia.nikkei.com · 02/08/2026

Iran war drives Asia EV boost but China slowdown weighs on overall sales Sales have doubled in Australia, India, South Korea and Vietnam since start of conflict trib.al/pNVEIvZ

031

Reposted by Dr Satoshi Akima, FRACP

Laura Phillips @lauraphillips.bsky.social · 01/08/2026

Sir #DavidAttenborough “Things are going to get worse. This is the new extinction. We are in terrible, terrible trouble and the longer we wait to do something about it, the worse it is going to get." #ClimateEmergency

vox.com

David Attenborough, the voice of Our Planet: “Things are going to get worse”

The voice of some of the most stunning nature documentaries ever made is pessimistic about the future of wildlife on earth.

27393114109

Reposted by Dr Satoshi Akima, FRACP

MedPage Today @medpagetoday.com · 02/08/2026

The risk of acute kidney injury following elective cardiac surgery was largely reduced with a short course of SGLT2 inhibitor therapy, a Dutch trial found. www.medpagetoday.com/cardiology/pre…

medpagetoday.com

Dapagliflozin Makes Good on Preventing Cardiac Surgery-Associated AKI

4 days of the SGLT2 inhibitor lowered the incidence of AKI substantially

092

Reposted by Dr Satoshi Akima, FRACP

Ian Weissman, DO @drianweissman.bsky.social · 02/08/2026

Studies are increasingly finding that bilingual people, who have native command of two languages, or multilinguals, who are able to speak more than two languages, are able to maintain their brains younger and healthier for longer. www.medicalnewstoday.com/articles/can...

medicalnewstoday.com

Speaking several languages protects the aging brain: Here's how

Bilinguals and multilinguals may stay younger for longer and have more agile brains. This Special Feature shows just how language proficiency protects the brain.

911432

Reposted by Dr Satoshi Akima, FRACP

aspneph.bsky.social @aspneph.bsky.social · 01/08/2026

Urea vs. tolvaptan for hospitalized patients with SIADH. academic.oup.com/ndt/advance-...

031

Dr Satoshi Akima, FRACP @toshiakima.bsky.social · 02/08/2026

IL-6 also has anti-inflammatory and regenerative functions, despite its primary reputation as a classic pro-inflammatory acute-phase cytokine. Classical signaling is associated with regenerative and anti-inflammatory functions, while trans-signaling is linked to pro-inflammatory functions

173

Reposted by Dr Satoshi Akima, FRACP

Nancy Malek @n95anaesthetist.bsky.social · 29/07/2026

1/🧵 IMPORTANT ANNOUNCEMENT FOR AUSTRALIANS SEEKING NUVAXOVID (NOVAVAX). Today I received a Nuvaxovid (Novavax) vaccination - my first COVID-19 vaccination in more than three years.

28439

Reposted by Dr Satoshi Akima, FRACP

Kidney International @kidneyint.bsky.social · 27/07/2026

Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy doi.org/10.1016/j.kint.2026.05.017 #MedSky #NephSky #OpenAccess #membranousnephropathy #nephroticsyndrome

042

Reposted by Dr Satoshi Akima, FRACP

Dr David Joffe MB BS(Hons), PhD, FRACP @davidjoffe64.bsky.social · 26/07/2026

For those interested in my obsessions and concerns with respect to Cøvid... Here's a link to talk, @andrewewing11.bsky.social and I presented at the Kirby Institute at the invitation of Prof Raina MacIntyre 👇🏻👇🏻👇🏻 youtu.be/qg15z_88Q48?...

youtu.be

Prof Andrew Ewing & Dr David Joffe — COVID-related Neurological Sequelae: From Delphi to Dopamine

YouTube video by Kirby Institute

69741

Reposted by Dr Satoshi Akima, FRACP

Dr Noor Bari @njbbari3.bsky.social · 26/07/2026

Person: I’m very sorry, I’ve got seven members of the team off sick with the flu. We are unable to do the job. Me: That’s why I wear this.

Me, wearing a Trident respirator standing in front of a poster about airborne disease spread in hospitals at ACEM 2025 ASM.

1549081

Reposted by Dr Satoshi Akima, FRACP

Ian Weissman, DO @drianweissman.bsky.social · 26/07/2026

A hospital pediatrician who has treated children severely ill with measles says: “The child is hunched over, mouth open, drooling, crying, maybe not even producing tears, because they’re so dehydrated." kffhealthnews.org/public-healt...

kffhealthnews.org

‘The Child Is Terrified’: Doctors on the Front Lines of a Measles Comeback Speak Out - KFF Health News

Hear from six pediatricians in measles hot spot Utah as the U.S. faces infection levels not seen in over three decades and prepares to lose its status as a country that eliminated the dangerous diseas...

57740

Reposted by Dr Satoshi Akima, FRACP

TRAstonDrs @castltrastondrs.medsky.network · 26/07/2026

#Medsky🧪 #IDsky #Obsky #pedsky #publichealth #vaccinesmatter #Vaccines are essential for safeguarding young lives and preventing potentially severe neurological complications from infection. Although vertical transmission of #SARSCoV2 from mother to fetus is rare, www.nature.com/articles/s41...

nature.com

The association of in utero SARS-CoV-2 exposure on neurodevelopmental outcomes at 12 and 22 months - Journal of Perinatology

Journal of Perinatology - The association of in utero SARS-CoV-2 exposure on neurodevelopmental outcomes at 12 and 22 months

2155

Reposted by Dr Satoshi Akima, FRACP

Robert Reich @rbreich.bsky.social · 24/07/2026

The decimation of our federal agencies has upended the lives of thousands of workers. These are the people who oversee food safety, public health, and much more. The squalor of this moment is bringing us back to basics — and reminding us of what our priorities should be. [Cartoon by Adam Zyglis]

20164622248

Reposted by Dr Satoshi Akima, FRACP

ThatIngrid @thatingrid.bsky.social · 24/07/2026

@airspotrob.bsky.social so cool to see this ready for hire at my local library

0254